AMCRAMCOR PLCLarge cap · $19.62B · FY ending 2025-06-30
$42.43-1.74% · 2026-07-13 · EOD
57/100 composite
A transparent blend of the four reads below — each opens into the tool it comes from. Not advice.Quality34
thin moat · ROIC 5%Value36
P/E 132.6 · 81% of 12-mo rangeMomentum84
golden · price above 200-daySmart Money72
buying · 0 funds · 0P/0S insidersBullish stackGolden crossAbove 200-day
vs S&P 500+380.7%
6-mo excess Trailing performance1M +11.2%
3M +3.1%
6M +389.4%
YTD +404.5%
1Y +331.6%
P/E vs its last 12 months (our price history): 24.4 low → 158.1 high
Current price sits at the 81th percentile of that window — near the top (richer). We only compare against the price history we own (no paid multi-year multiples — nothing invented).
No clear moat — ROIC 5%
Piotroski F3/9
fundamental strength Altman ZDistress
bankruptcy zone ROIC = NOPAT ÷ (debt + equity − cash), using an effective tax rate of 21%. Annual figures from SEC XBRL.
Dividend & capital return
Payout ratio124.6%
above earnings Shareholder yield4.3%
dividends + buybacks Annual figures from SEC cash-flow statements. Shareholder yield = total cash returned ÷ market cap.
Net buying0P / 0S insiders · 0 funds hold · 1 Congress buys
CongressThomas H. Kean JrBUY2026-05-14
Chealth · 60/100
Self-fundingSelf-funding — profitable · generates cash
- ●Bankruptcy-risk zone Altman Z-Score is in the distress zone (1.03).
Educational tools — not financial advice. Fundamentals from SEC EDGAR (XBRL); prices are end-of-day (Databento). Scores are a transparent blend of the components shown, computed on our own data — a research aid, not a recommendation.